Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 476
Immune Disorders Drugs 202
Drug Discovery 170
Cardiovascular Drugs 157
Infectious Diseases Drugs 135
Biopharmaceuticals 130
Clinical Trials 125
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 85
Hematological Drugs 84
Liver and Kidney Disorders Drugs 79
Lymphoma Drugs 62
Diabetes Drugs 55
Dermatological Drugs 55
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 42
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Drug Delivery 37
Pharmaceutical Intermediates 36
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 32
Infusions and Injectables 30
Liver Cancer Drugs 28
Analgesics 25
Drugs by Therapeutic Area 24
Bladder Cancer Drugs 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Schizophrenia Drugs 19
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Breast Cancer Drugs 14
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Alzheimer's Disease Drugs 8
Optical Disorders Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



274 reviews

2,452 Results (Page 12 of 123)
- Relevance
  Sort by

Muscle Invasive Bladder cancer- Pipeline Insight, 2024

 Clinical Trials
August 2024
60 Pages
Global

From

€1365EUR$1,500USD£1,170GBP

Bladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
734 Pages
Global

From

€2275EUR$2,500USD£1,951GBP

Anti-Retroviral Drugs Market - Growth, Trends, COVID-19 and Forecasts (2023-2028)

 Report
April 2023
110 Pages
Global

From

€4323EUR$4,750USD£3,706GBP

Hepatitis C Treatment Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application

 Report
February 2022
87 Pages
Global

From

€3200EUR$3,767USD£2,839GBP

HIV Diagnostics Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

 Report
April 2025
182 Pages
Global

From

€4095EUR$4,500USD£3,511GBP

NEED HELP FINDING THE RIGHT PRODUCT? Farid will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Colorectal Cancer Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

 Report
February 2024
172 Pages
Global

From

€4095EUR$4,500USD£3,511GBP

United States Pre-Exposure Prophylaxis (PrEP) Market, Competition, Forecast and Opportunities, 2018-2028

 Report
October 2023
78 Pages
United States

From

€3185EUR$3,500USD£2,731GBP

Tuberculosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
September 2022
359 Pages
Global

From

€2275EUR$2,500USD£1,951GBP

Kidney Cancer (Renal Cell Cancer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
322 Pages
Global

From

€2275EUR$2,500USD£1,951GBP

Brain Tumor Drugs Market Analysis & Forecast 2024-2034: Market; By Therapy; By Indication; By Distribution Channel; and By Region

 Report
October 2023
145 Pages
Global

From

€2867EUR$3,150USD£2,458GBP

Bladder Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

 Report
November 2022
1018 Pages
Global

From

€2275EUR$2,500USD£1,951GBP

Liver Cancer Drug Market Size, Share & Trends Analysis Report by Therapy (Targeted Therapy, Immunotherapy, Chemotherapy), Type (Hepatocellular Carcinoma), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), Region, and Segment Forecasts 2025-2030

 Report
February 2025
100 Pages
Global

From

€5415EUR$5,950USD£4,642GBP

Schizophrenia Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Liver Diseases Treatment - Global Strategic Business Report

 Report
April 2025
194 Pages
Global

From

€5324EUR$5,850USD£4,564GBP

Global Dendritic Cell Cancer Vaccine Immunotherapy Market, Dosage, Price & Clinical Trials Insight 2026

 Report
October 2020
222 Pages
Global

From

€2730EUR$3,000USD£2,341GBP

Lung Cancer Therapeutics Market 2025-2033

 Report
March 2025
140 Pages
Global

From

€2729EUR$2,999USD£2,340GBP

Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
1560 Pages
Global

From

€2275EUR$2,500USD£1,951GBP

Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2025

 Report
April 2025
750 Pages
Global

From

€3636EUR$3,995USD£3,117GBP

Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2025

 Report
April 2025
250 Days
Global

From

€3636EUR$3,995USD£3,117GBP

Small Cell Lung Cancer Therapeutics Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

2,452 Results (Page 12 of 123)
- 1
- 10
- 11
- 12
- 13
- 14

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.